Video Link: https://www.youtube.com/watch?v=a6EJC3BQdFQ

Pharmacogenomic analyses have become a key part of state-of-the-art drug trials, but the pharmaceutical companies funding and organizing those trials have often been stymied in collecting and using genetic specimens from study participants. Dr.

See more here:
Drug Firms Want More Access to Genetic Specimens - Video